Fasting plasma glucose is an independent predictor for severity of H1N1 pneumonia

BMC Infectious Diseases

Jinchao Zhang³  Ying Xiang³  Xiwen Sun⁴  Jiajun Wang¹  Bo Qiu²  Qiang Li³  Hong Chen⁵  Wei Wang³ 

[1] Department of Computer, Second Hospital of Harbin Medical University, Harbin 150086, China;Department of Neurosurgery, First Hospital of China Medical University, Shenyang, 110001, China;Department of Endocrinology, Second Hospital of Harbin Medical University, Harbin 150086, China;Department of Cancer epidemiology research, Cancer Research Institute of Harbin Medical University, Harbin 150086, China;Department of Respirology, Second Hospital of Harbin Medical University, Harbin 150086, China

关键词: Fasting plasma glucose (FPG);    Pneumonia;    Influenza A (H1N1);   

Others  :  1175745
DOI  :  10.1186/1471-2334-11-104

 received in 2010-09-27, accepted in 2011-04-21,  发布年份 2011

【 摘 要 】

Background

The pandemic influenza A (H1N1) virus emerged during 2009 and has spread worldwide. This virus can cause injuries to the lungs, liver, and heart. However, data regarding whether this influenza virus can affect pancreatic islets are limited. We investigated the effects of influenza A (H1N1) pneumonia on fasting plasma glucose (FPG) and islet function, and evaluated possible correlations between biochemical test results and the severity of H1N1 pneumonia.

Methods

We performed a retrospective analysis of patients either diagnosed with or suspected of having H1N1 pneumonia who were admitted to our hospital in 2009. Possible associations between FPG levels and H1N1 virus infection were assessed by logistic regression. Correlation and regression analyses were used to assess relationships between FPG and biochemical test results. Associations between admission days and significant data were assessed by single factor linear regression. To evaluate effects of H1N1 on pancreatic β-cell function, results of a resistance index (homa-IR), insulin function index (homa-β), and insulin sensitivity index (IAI) were compared between a H1N1 group and a non-H1N1 group by t-tests.

Results

FPG was significantly positively associated with H1N1 virus infection (OR = 1.377, 95%CI: 1.062-1.786; p = 0.016). FPG was significantly correlated with AST (r = 0.215; p = 0.039), LDH (r = 0.400; p = 0.000), BUN (r = 0.28; p = 0.005), and arterial Oxygen Saturation (SaO₂; r = -0.416; p = 0.000) in the H1N1 group. H1N1 patients who were hypoxemic (SaO₂<93%) had higher FPG levels than those who were not hypoxic (9.82 ± 4.14 vs. 6.64 ± 1.78; p < 0.05). FPG was negatively correlated with SaO₂ in the H1N1 group with hypoxia (SaO₂<93; r = -0.497; p = 0.041). SaO₂ levels in patients with high FPG levels (≥7 mmol/L) were significantly lower than those of H1N1 patients with low FPG levels (<5.6 mmol/L). There were no significant differences in homa-IR, homa-β, or IAI between the H1N1 and non-H1N1 groups after adjusting for age, sex, and BMI.

Conclusions

FPG on admission could be an independent predictor for the severity of H1N1 pneumonia. Elevated FPG induced by H1N1 pneumonia is not a result of direct damage to pancreatic β-cells, but arises from various factors' combinations caused by H1N1 virus infection.

【 授权许可】

   
2011 Wang et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Centers for Disease Control and Prevention (CDC): Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009, 58:1071-4.
• [2]Centers for Disease Control and Prevention (CDC): Outbreak of swine-origin influenza A (H1N1) virus infection-Mexico, March-April 2009. MMWR Morb Mortal WklyRep 2009, 58:467-70.
• [3]World Health Organization: Influenza A (H1N1)-update 79. [http://www.who.int/csr/don/2009_12_18a/en/index.html] webcite
• [4]Dee S, Jayathissa S: Clinical and epidemiological characteristics of the hospitalised patients due to pandemic H1N1 2009 viral infection: experience at Hutt Hospital, New Zealand. N Z Med J 2010, 123:45-53.
• [5]Hanslik T, Boelle PY, Flahault A: Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A (H1N1)2009 influenza virus, France, 2009-2010. PLoS Curr Influenza 2010, RRN1150.
• [6]Barboza P, Baudon C, Chérié-Challine L, Gastellu-Etchegorry M, Gueguen J, La Ruche G, Grangeon JP, Laumond-Barny S, Noël M, Pfannstiel A, Chee-Ayee A, Daudens E, Frogier E, Le B, Mallet HP, Pescheux JP, Vergeaud H, Lastère S, Dutaut E, Yvon JF: Influenza A (H1N1)2009 in the French Pacific territories: assessment of the epidemic wave during the austral winter. Clin Microbiol Infect 2010, 16:304-8.
• [7]World Health Organization: Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance. [http://www.who.int/csr/resources/publications/swineflu/interim_guidance/en/] webcite
• [8]Ministry of Health of The People's Republic of China [http:/ / 61.49.18.65/ publicfiles/ business/ cmsresources/ H1N1/ cmsrsdocument/ doc6806.doc] webcite
• [9]Monzillo LU, Hamdy O: Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 2003, 61:397-412.
• [10]Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al.: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23:57-63.
• [11]Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, Samuel MC, Rosenberg J, Talarico J, Hatch D, California Pandemic (H1N1) Working Group: Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-902.
• [12]Fajardo-Dolci G, Gutierrez-Vega R, Arboleya-Casanova H, Villalobos A, Wilson KS, García SG, Sotelo J, Córdova Villalobos JA, Díaz-Olavarrieta C: Clinical characteristics of fatalities due to influenza A (H1N1) virus in Mexico. Thorax 2010, 65:505-9.
• [13]Allard R, Leclerc P, Tremblay C, Tannenbaum TN: Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care 2010, 33:1491-3.
• [14]Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler RA, Canadian Critical Care Trials Group H1N1 Collaborative: Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302:1872-9.
• [15]Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, Martinez MA, Rivero E, Valdez R, Ruiz-Palacios G, Hernández M, Stewart TE, Fowler RA: Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302:1880-7.